Posts by Drucilla J. Roberts, MD
-
No Link Between COVID-19 and Stillbirth Detected, But Placental Vascular Pathology is Worrisome
Obstetrician-gynecologists at Massachusetts General Hospital determined that during the first five months of the COVID-19 pandemic in Boston, there was no change in the rate of third-trimester stillbirth, but there was an increase in placental vascular malperfusion compared with the two prior years.
Biography
Dr. Roberts's area of expertise and interest is in perinatal pathology - surgical and autopsy pathology. She has a special interest in understanding the biology and clinical significance of pathologic findings. She has been invited to participate in the NICHD’s “white paper” meetings for the Human Placental Project in 2014 and 2015. She works on perinatal projects focusing on the placenta both in the US and internationally. She is active in global health working in teaching and practice (anatomic pathology and laboratory services) in sub-Saharan Africa and has projects including placental malaria, stillbirths, and autopsy pathology in resource-poor settings. She directed the first ever Harvard Medical School CME course in Sub-Saharan Africa titled "The contribution of anatomic pathology to the health of women and children" with faculty from the USA, South Africa, and Ethiopia in 2011 and in Nigeria in 2013. In 2012 she participated in the Multidisciplinary Cancer Management Course (MCMC), in Eldoret, Kenya, presented by the American Society of Clinical Oncology (ASCO) in partnership with ASCP and the Academic Model for the Provision of Access to Health Care (AMPATH). Dr. Roberts is interested in highlighting the improvements pathologists can make for all patients. Her aim is to raise awareness of issues that can lead to improvements in pathology especially in sub-Saharan Africa.
Obstetrics & Gynecology Care at Mass General
The Mass General Department of Obstetrics & Gynecology offers the highest level of care to women. Our clinical and research team is a leader in advancing treatments for gynecologic cancers, menopause, high-risk obstetrics, infertility and urogynecology.